Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: CA Cancer J Clin. 2011 May 26;61(4):250–281. doi: 10.3322/caac.20114

Table 2.

Clinically applied photosensitizers.

Photosensitizer Structure Wavelength
(nm)
Approved Trials Cancer types
Photofrin (HPD) porphyrin 630 World wide lung, esophagus, bile duct, bladder, brain,
ovarian
ALA porphyrin
precursor
635 World wide skin, bladder, brain, esophagus
ALA esters porphyrin
precursor
635 Europe skin, bladder
Foscan (mTHPC) Chlorine 652 Europe US head and neck, lung, brain, skin, bile duct
Verteporfin Chlorine 690 World wide
(AMD)
UK ophthalmic, pancreatic, skin
HPPH chlorin 665 US head and neck, esophagus, lung
Purlytin (SnEt2) chlorin 660 US skin, breast
Taloporfin, LS11, MACE, Npe6 chlorin 660 US liver, colon, brain
Fotolon (PVP-Ce6), Radachlorin,
Photodithazine
chlorin 660 Belarus,
Russia
nasopharyngeal, sarcoma, brain
Silicon phthalocyanine (PC4) phthalocyanine 675 US cutaneous T cell lymphoma
Padoporfin (TOOKAD) bacteriochlorin 762 US prostate
Motexafin lutetium (LuTex) texaphyrin 732 US breast